IN2013MN01890A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MN01890A IN2013MN01890A IN1890MUN2013A IN2013MN01890A IN 2013MN01890 A IN2013MN01890 A IN 2013MN01890A IN 1890MUN2013 A IN1890MUN2013 A IN 1890MUN2013A IN 2013MN01890 A IN2013MN01890 A IN 2013MN01890A
- Authority
- IN
- India
- Prior art keywords
- plasma
- factor
- deficient
- coagulation
- factors
- Prior art date
Links
- 108010039209 Blood Coagulation Factors Proteins 0.000 abstract 3
- 102000015081 Blood Coagulation Factors Human genes 0.000 abstract 3
- 239000003114 blood coagulation factor Substances 0.000 abstract 3
- 230000002950 deficient Effects 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- 108010094028 Prothrombin Proteins 0.000 abstract 2
- 239000003146 anticoagulant agent Substances 0.000 abstract 2
- 229940127219 anticoagulant drug Drugs 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 230000015271 coagulation Effects 0.000 abstract 2
- 238000005345 coagulation Methods 0.000 abstract 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 108010014173 Factor X Proteins 0.000 abstract 1
- 108010073385 Fibrin Proteins 0.000 abstract 1
- 102000009123 Fibrin Human genes 0.000 abstract 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 1
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 229950003499 fibrin Drugs 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS050010A IS2809B (is) | 2011-03-08 | 2011-03-08 | Blóðstorkumæling |
| PCT/IS2012/050005 WO2012120546A2 (en) | 2011-03-08 | 2012-03-08 | Method for monitoring anticoagulant therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013MN01890A true IN2013MN01890A (cg-RX-API-DMAC7.html) | 2015-09-25 |
Family
ID=46682867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1890MUN2013 IN2013MN01890A (cg-RX-API-DMAC7.html) | 2011-03-08 | 2012-03-08 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9234902B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2684056B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103534595B (cg-RX-API-DMAC7.html) |
| DK (1) | DK2684056T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2636318T3 (cg-RX-API-DMAC7.html) |
| IN (1) | IN2013MN01890A (cg-RX-API-DMAC7.html) |
| IS (1) | IS2809B (cg-RX-API-DMAC7.html) |
| RU (1) | RU2607658C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012120546A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015154090A1 (en) * | 2014-04-04 | 2015-10-08 | Bloodworks | Routine laboratory and point-of-care (poc) testing for hemostasis |
| EP3140650B1 (en) * | 2014-05-05 | 2022-07-20 | Haemonetics Corporation | Methodologies and reagents for detecting fibrinolysis and hyperfibrinolysis |
| SE540132C2 (sv) * | 2014-05-22 | 2018-04-10 | Zafena Ab | Analysmetod för bestämning av antikoagulanter i blod eller blodplasma |
| CN110822822B (zh) | 2014-06-09 | 2021-08-24 | 泰尔茂比司特公司 | 冻干法 |
| JP6871673B2 (ja) * | 2015-03-31 | 2021-05-12 | 学校法人東日本学園 | 血液検体を判定するための方法、装置及びコンピュータプログラム、並びに血液検体分析装置 |
| WO2016170944A1 (ja) * | 2015-04-24 | 2016-10-27 | 公立大学法人奈良県立医科大学 | 血液検体の凝固能の評価方法、並びにその方法に用いるための試薬、試薬キット及び装置 |
| EP3401686B1 (en) * | 2016-01-07 | 2022-10-05 | Fujimori Kogyo Co., Ltd. | Method for analyzing blood characteristics |
| RU2655302C1 (ru) * | 2017-05-15 | 2018-05-24 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Способ прогнозирования эффективности антикоагулянтной терапии у больных с фибрилляцией предсердий, перенесших инсульт |
| RU2660706C1 (ru) * | 2017-09-26 | 2018-07-09 | федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ПМ" Минздрава России) | Скрининг-тест определения контактного пути коагуляции (СТОКПК) |
| CN111295094A (zh) | 2017-10-09 | 2020-06-16 | 泰尔茂比司特生物技术有限公司 | 冻干容器及使用冻干容器的方法 |
| CN109459420B (zh) * | 2018-12-29 | 2021-06-04 | 华南师范大学 | 一种水体中二/三价铁离子的检测方法 |
| WO2020242552A1 (en) | 2019-03-14 | 2020-12-03 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
| CN110361531B (zh) * | 2019-08-02 | 2023-04-11 | 天津医科大学总医院 | 一种检测微粒促凝活性的实验方法 |
| US20220373566A1 (en) * | 2019-10-17 | 2022-11-24 | Nova Biomedical Corporation | Coagulation assay apparatus and methods thereof |
| CN114544983A (zh) * | 2022-02-28 | 2022-05-27 | 南京可诺医疗技术有限公司 | 一种凝血与血小板功能分析仪用正常值质控品的制备方法 |
| CN114778858A (zh) * | 2022-06-23 | 2022-07-22 | 深圳市帝迈生物技术有限公司 | 一种狼疮抗凝物检测试剂盒 |
| WO2025132651A1 (en) * | 2023-12-20 | 2025-06-26 | Pentapharm Ag | Method for analyzing a blood sample with respect to a hemostatic regulator |
| WO2025186634A1 (en) | 2024-03-04 | 2025-09-12 | Fiix Diagnostics | Method and kit for monitoring anticoagulant therapy |
| US12405281B1 (en) | 2024-03-04 | 2025-09-02 | Fiix Diagnostics | Method and kit for monitoring anticoagulant therapy |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL238873A (cg-RX-API-DMAC7.html) * | 1958-05-16 | |||
| US3395210A (en) * | 1964-02-07 | 1968-07-30 | Warner Lambert Pharmaceutical | Lyophilized diagnostic reagent for the determination of blood coagulation factors |
| AT350726B (de) * | 1976-08-30 | 1979-06-11 | Immuno Ag | Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma |
| DE3413311A1 (de) | 1984-04-09 | 1985-10-17 | Behringwerke Ag, 3550 Marburg | Reagenz zur bestimmung der thromboplastinzeit |
| AU2870992A (en) | 1991-10-04 | 1993-05-03 | Board Of Regents Of The University Of Nebraska, The | A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins |
| US5447440A (en) * | 1993-10-28 | 1995-09-05 | I-Stat Corporation | Apparatus for assaying viscosity changes in fluid samples and method of conducting same |
| US6194394B1 (en) | 1998-07-01 | 2001-02-27 | Sigma-Aldrich Co. | Coagulation controls for prothrombin time (PT) and activated partial thromboplastin time (APTT) assays |
| CN1255637A (zh) * | 1998-09-03 | 2000-06-07 | 希森美康株式会社 | 抗凝血剂及血液检查方法 |
| CN1806176A (zh) | 2003-05-16 | 2006-07-19 | 国家生物标准及控制研究所 | 混合物 |
| ZA200601974B (en) * | 2003-09-22 | 2007-05-30 | Haematex Res Pty Ltd | Method for detecting procoagulant phospholipid |
| SE0303249D0 (sv) * | 2003-12-02 | 2003-12-02 | Inst Polymerutveckling Ab | Hematocrit and analyte concentration determination |
| CN1952169B (zh) * | 2005-10-18 | 2010-05-12 | 上海太阳生物技术有限公司 | 临床检验凝血酶原时间(pt)测定体外诊断试剂盒 |
| CN101221189B (zh) * | 2007-01-12 | 2012-08-15 | 上海太阳生物技术有限公司 | 一种用于测定活化部分凝血活酶时间aptt的体外诊断试剂盒 |
| CN101526538B (zh) * | 2008-03-09 | 2014-04-09 | 上海长岛生物技术有限公司 | 液体白陶土aptt试剂 |
| EP2177624A1 (en) | 2008-10-02 | 2010-04-21 | Siemens Healthcare Diagnostics Products GmbH | Blood coagulation assays |
-
2011
- 2011-03-08 IS IS050010A patent/IS2809B/is unknown
-
2012
- 2012-03-07 US US13/414,112 patent/US9234902B2/en active Active
- 2012-03-08 WO PCT/IS2012/050005 patent/WO2012120546A2/en not_active Ceased
- 2012-03-08 CN CN201280021851.3A patent/CN103534595B/zh active Active
- 2012-03-08 ES ES12748059.8T patent/ES2636318T3/es active Active
- 2012-03-08 DK DK12748059.8T patent/DK2684056T3/en active
- 2012-03-08 EP EP12748059.8A patent/EP2684056B1/en active Active
- 2012-03-08 RU RU2013144950A patent/RU2607658C2/ru active
- 2012-03-08 IN IN1890MUN2013 patent/IN2013MN01890A/en unknown
-
2015
- 2015-12-03 US US14/957,883 patent/US20160108457A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2684056A2 (en) | 2014-01-15 |
| WO2012120546A3 (en) | 2012-11-29 |
| ES2636318T3 (es) | 2017-10-05 |
| RU2607658C2 (ru) | 2017-01-10 |
| IS2809B (is) | 2012-10-15 |
| CN103534595A (zh) | 2014-01-22 |
| US20120231485A1 (en) | 2012-09-13 |
| US20160108457A1 (en) | 2016-04-21 |
| EP2684056B1 (en) | 2017-05-03 |
| RU2013144950A (ru) | 2015-04-20 |
| CN103534595B (zh) | 2016-03-09 |
| DK2684056T3 (en) | 2017-07-10 |
| US9234902B2 (en) | 2016-01-12 |
| WO2012120546A2 (en) | 2012-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2013MN01890A (cg-RX-API-DMAC7.html) | ||
| BR112016004320A2 (pt) | biossensor, sistema, kit, métodos de determinação ou de identificação e de quantificação de uma concentração de amônia ou íon amônio, de diagnóstico de uma doença metabólica em um sujeito, de determinação da resposta do paciente a uma terapia, de fabricação de um biossensor, de um sistema ou de qualquer tira de teste e de detecção da presença, ausência, ou quantidade de aminoácidos em uma amostra, e, tira de teste | |
| MX2010004465A (es) | Metodo y aparato para deteccion electroquimica. | |
| WO2011079938A3 (en) | System and method for determining the concentration of an analyte in a sample fluid | |
| ATE539675T1 (de) | System und verfahren zur bestimmung einer analytenkonzentration mit einer hämatokrit- korrektur | |
| MX2015005276A (es) | Sistema y metodos para diagnostico de la salud. | |
| BR112012024945A2 (pt) | sistema e método de medição eletroquímica de analitos | |
| WO2012159021A3 (en) | Portable hemostasis analyzer | |
| NZ621733A (en) | Lung cancer biomarkers and uses thereof | |
| WO2014036495A3 (en) | Diagnostic assays and kits for detection of folate receptor 1 | |
| TW200617380A (en) | Concentration determination in a diffusion barrier layer | |
| EA030186B9 (ru) | Способ проведения количественных анализов | |
| BR112014031509B8 (pt) | Método para a determinação simultânea in vitro em tempo real do curso da atividade da enzima proteolítica e da resistência do coágulo de fibrina, reômetro rotativo e uso de um reômetro rotativo | |
| WO2009152269A3 (en) | Methods of quantifying biomarkers | |
| GB201207297D0 (en) | Analytical methods and arrays for use in the same | |
| IN2014DE01077A (cg-RX-API-DMAC7.html) | ||
| BR112013005442A2 (pt) | método de medição de analito e sistema com compensação de hematócrito | |
| MX2015003740A (es) | Metodo para evaluar la reaccion de coagulacion sanguinea. | |
| NZ594772A (en) | Diagnosis and prognosis of renal injury and renal failure using vitamin k dependent protein c | |
| WO2010099137A3 (en) | In situ methods for monitoring the emt status of tumor cells in vivo | |
| Zhao et al. | Building and evaluating the autoverification of coagulation items in the laboratory information system | |
| ATE514951T1 (de) | Verfahren zur prüfung eines mehrkanaligen elements zur blutanalyse | |
| MX2009001070A (es) | Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma. | |
| ATE550668T1 (de) | Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis | |
| ATE426175T1 (de) | Verfahren zur standardisierung von gerinnungstesten |